Author: Himanshu Patni
12 August 2023
The transplantation market refers to the healthcare sector that encompasses the various aspects of organ and tissue transplantation procedures. It involves the procurement, preservation, transportation, and transplantation of organs, tissues, and cells from a donor to a recipient. The goal of transplantation is to replace a damaged or non-functioning organ or tissue with a healthy one, thereby restoring or improving the recipient’s health and quality of life. The transplantation market includes a wide range of organ and tissue transplantations, such as heart, lung, liver, kidney, pancreas, cornea, bone marrow, and stem cell transplants.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=42980
These procedures are performed to treat various conditions and diseases, including end-stage organ failure, certain cancers, genetic disorders, autoimmune diseases, and severe injuries. The development of immunosuppressive drugs and advancements in diagnostic technologies have played a significant role in propelling the growth of the transplantation market in North America. These advancements have improved patient outcomes, increased the success rates of transplantation procedures, and expanded access to transplantation for individuals in need. Immunosuppressive drugs are a cornerstone of transplantation as they suppress the recipient’s immune system to prevent organ rejection. Over the years, there have been notable developments in immunosuppressive drugs that have enhanced their efficacy and safety profiles. These advancements have led to improved long-term graft survival and reduced the risk of complications. Immunosuppressive drug regimens are continuously refined, personalized, and tailored to the individual patient, contributing to better outcomes. For instance, in 2021, Astellas Pharma received FDA approval for Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). While not directly related to transplantation, this development showcases the advancements in immunosuppressive therapies and their potential in treating autoimmune diseases, which can impact transplantation outcomes. Furthermore, Advancements in diagnostic technologies have also contributed to the growth of the transplantation market in North America. Accurate and efficient diagnostic methods are essential for assessing organ compatibility, monitoring rejection, and individualizing immunosuppressive therapy.
Further, the North America Transplantation Market is expected to grow at a strong CAGR of 5.0% during the forecast period (2022-2030). In summary, the ongoing efforts of pharmaceutical companies and diagnostic technology providers in North America to advance the field of transplantation. These advancements contribute to better patient care, improved outcomes, and the overall growth of the transplantation market in the region. Continued research and development in immunosuppressive drugs and diagnostic technologies are crucial for further enhancing transplantation success rates and expanding access to transplantation for patients in need.
North America Transplantation Market Revenue (2020-2030)- USD Mn
For a detailed analysis of the Global Transplantation Market browse through – https://univdatos.com/report/transplantation-market/
Based on product, the market is segmented into tissue products, immunosuppressive drugs, and preservation solutions. Among them, the tissue products segment captured a significant share of the market in 2021. Tissue products, immunosuppressants, and preservation solutions are the most common products used in tissue or organ transplantation. The growing number of transplantation procedures, such as cochlear, heart valve, bone marrow, and orthopedic soft tissues, is related to the segment’s expansion. Furthermore, new product development is supporting market expansion.
Based on the application, the market is bifurcated into organ transplantation and tissue transplantation. Among them, the tissue transplantation segment is expected to grow at a higher CAGR in the market. This is because skin, cornea, bones, heart valves, tendons, nerves, and veins replacement are the most regularly performed procedures worldwide. The increasing number of burn and injury cases is likely to drive tissue product demand.
Global Transplantation Market Segmentation
Market Insight, by Product
· Tissue Products
· Immunosuppressive Drugs
· Preservation Solutions
Market Insights, by Application
· Organ Transplantation
· Tissue Transplantation
Market Insights, by End-Users
· Hospitals
· Transplantation Centers
· Others
Market Insight, by Region
· North America Transplantation Market
o U.S.
o Canada
o Rest of North America
· Europe Transplantation Market
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
· Asia-Pacific Transplantation Market
o China
o India
o Japan
o Rest of Asia-Pacific
· Rest of the World Transplantation Market
Top Company Profiles
· Abbvie, Inc
· Arthrex, Inc.
· Zimmer Biomet
· Medtronic
· Novartis AG
· Strykers
· F. Hoffmann-La Roche Ltd
· BiolifeSolutions, Inc
· Teva Pharmaceuticals
· Veloxis Pharmaceutical
Get a call back
